期刊文献+

度洛西汀联合小剂量奥氮平对83例抑郁症伴自杀倾向患者预后的影响分析 被引量:8

Effects of Duloxetine Combined with Low-dose Olanzapine on Prognosis of 83 Patients with Depression and Suicidal Tendency
下载PDF
导出
摘要 目的本文旨在观察度洛西汀联合小剂量奥氮平对抑郁症伴自杀倾向患者预后的影响。方法将83例精神分裂症患者随机分为观察组41例和对照组42例。对照组单用度洛西汀治疗;观察组在对照组基础上加用小剂量奥氮平治疗,疗程均为12周。采用汉密尔顿抑郁量表评分(HAMD)评分评估患者抑郁程度,采用自杀意念自评量表评分(SSIOS)评估患者自杀意念发生情况。结果两组治疗8、12周HAMD评分均较治疗前下降,且观察组下降显著,观察组治疗8周、12周自杀意念发生率分别为60.98%、41.46%显著低于对照组的80.95%、64.29%,两组治疗8、12周SSIOS评分均较治疗前下降,且观察组下降显著,差异均有统计学意义(P<0.05)。结论度洛西汀联合小剂量奥氮平治疗有效改善抑郁症伴自杀倾向患者抑郁症状,明显降低自杀意念发生率。 Objective To investigate the effects of duloxetine combined with low-dose olanzapine on prognosis of patients with depression and suicidal tendency.Methods 83 patients with schizophrenia were randomly divided into observation group(41 cases)and control group(42 cases).The control group was treated with duloxetine.The observation group was treated with low-dose olanzapine on the basis of the control group.The course of treatment was 12 weeks.The Hamilton Depression Scale(HAMD)was performed to assess depression degree of patients.The self-rating idea of suicide scale(SSIOS)was performed to assess the occurrence of suicidal ideation.Results HAMD scores of the two groups at 8 and 12 weeks after treatment were decreased compared with those before treatment.And the decrease in the observation group was significant.The occurrence rates of suicidal ideation in the observation group at 8 weeks and 12 weeks after treatment were 60.98%and 41.46%,respectively.Which were significantly lower than those in the control group(80.95%,64.29%).SSIOS scores of the two groups at 8 and 12 weeks after treatment were decreased compared with those before treatment.And the decrease in the observation group was significant(P<0.05).Conclusion Duloxetine combined with low-dose olanzapine is effective in improving depressive symptoms in patients with depression and suicidal tendency,and can significantly reduce the incidence of suicidal ideation.
作者 张映虹 ZHANG Ying-hong(The Third Ward of Nanyang Psychiatric Hospital of Henan,Nanyang 473083,Henan Province,China)
出处 《罕少疾病杂志》 2019年第2期22-24,共3页 Journal of Rare and Uncommon Diseases
关键词 度洛西汀 奥氮平 抑郁症伴自杀倾向 5-羟色胺(5-HT) 自杀意念 Duloxetine Olanzapine Depression and Suicidal Tendency 5-serotonin(5-HT) Suicidal Ideation
  • 相关文献

参考文献8

二级参考文献51

  • 1常鹏,杨成悌.心血管疾病并发抑郁症的调查及帕罗西汀的疗效观察[J].临床荟萃,2005,20(7):364-366. 被引量:6
  • 2苏晖,江开达,徐一峰,宋立升,虞一萍.抑郁症首次发病患者治疗前后认知功能的研究[J].中华精神科杂志,2006,39(1):20-23. 被引量:53
  • 3国效峰,赵靖平,陈晋东.度洛西汀:一种新型抗抑郁药[J].中国新药与临床杂志,2006,25(7):552-555. 被引量:89
  • 4孙学礼.难治性抑郁障碍及其药物治疗[J].中国处方药,2006(10):9-13. 被引量:10
  • 5汪向东 王希林 骊弘.心理卫生评定量表手册(增订版)[M].北京:中国心理卫生杂志社,1999.220-223.
  • 6Rayner L, Price A, Evans A, et al. Antidepressants for depression in physically ill people [ J ]. Cochrane Database Syst Rev, 2010, 3 : CD007503.
  • 7Slaughter JR, Slaughter KA, Nichols D, et al. Prevalence, clinical manifestations, etiology and treatment of depression in Parkinson's disease[J]. J Neuropsychiatry Clin Neurosci, 2001, 13 (2) : 187 - 196.
  • 8Cheour M, Ellouze F, Zine I, et al. Beck inventory depression assessment in chronic pain patients [ J ]. Tunis Med, 2008, 86 (12): 1074 -1078.
  • 9Elliott TE, Renier CM, Palcher JA. Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36 [J]. Pain Med, 2003, 4 (4): 331-339.
  • 10Scascighini L, Sprott H. Chronic nonmalignant pain: a challenge for patients and clinicians [ J ]. Nat Clin Pract Rheumatol, 2008, 4 (2) : 74 -81.

共引文献147

同被引文献66

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部